CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / Common Stock
Shares outstanding
123,180,519
Total 13F shares
23,293,467
Share change
-2,036,205
Total reported value
$25,386,000
Price per share
$1.09
Number of holders
46
Value change
-$1,705,125
Number of buys
9
Number of sells
32

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Broadfin Capital, LLC
13F
Company
6.7%
8,200,000
$5,822,000 30 Jun 2016
13F
BAKER BROS. ADVISORS LP
13F
Company
4.2%
5,122,153
$3,637,000 30 Jun 2016
13F
VANGUARD GROUP INC
13F
Company
2.4%
2,909,584
$2,066,000 30 Jun 2016
13F
Point72 Asset Management, L.P.
13F
Company
1.9%
2,366,964
$1,681,000 30 Jun 2016
13F
TANAKA CAPITAL MANAGEMENT INC
13F
Company
0.53%
653,352
$464,000 30 Jun 2016
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.53%
647,745
$460,000 30 Jun 2016
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.5%
619,777
$440,000 30 Jun 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
0.38%
469,440
$333,000 30 Jun 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.37%
460,026
$326,000 30 Jun 2016
13F
CREDIT SUISSE AG/
13F
Company
0.35%
425,076
$302,000 30 Jun 2016
13F
DEUTSCHE BANK AG\
13F
Company
0.28%
345,445
$245,000 30 Jun 2016
13F
BLACKROCK ADVISORS LLC
13F
Company
0.24%
301,727
$214,000 30 Jun 2016
13F
Paloma Partners Management Co
13F
Company
0.23%
282,261
$200,000 30 Jun 2016
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
0.2%
247,711
$176,000 30 Jun 2016
13F
DRW Securities, LLC
13F
Company
0.19%
237,200
$168,000 30 Jun 2016
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.15%
189,607
$135,000 30 Jun 2016
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.15%
180,721
$128,000 30 Jun 2016
13F
ROYAL BANK OF CANADA
13F
Company
0.13%
165,000
$117,000 30 Jun 2016
13F
A.R.T. Advisors, LLC
13F
Company
0.1%
126,289
$89,000 30 Jun 2016
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.09%
112,310
$80,000 30 Jun 2016
13F
LMR Partners LLP
13F
Company
0.09%
112,476
$79,000 30 Jun 2016
13F
CORRADO ADVISORS, LLC
13F
Company
0.08%
103,300
$73,000 30 Jun 2016
13F
Alpine Global Management, LLC
13F
Company
0.08%
102,782
$73,000 30 Jun 2016
13F
NORTHERN TRUST CORP
13F
Company
0.07%
89,786
$64,000 30 Jun 2016
13F
Bank of New York Mellon Corp
13F
Company
0.07%
83,266
$59,000 30 Jun 2016
13F
Weiss Multi-Strategy Advisers LLC
13F
Company
0.06%
69,255
$49,000 30 Jun 2016
13F
JANE STREET GROUP, LLC
13F
Company
0.05%
65,594
$47,000 30 Jun 2016
13F
Tower Research Capital LLC (TRC)
13F
Company
0.05%
55,783
$40,000 30 Jun 2016
13F
UBS Group AG
13F
Company
0.04%
53,536
$38,000 30 Jun 2016
13F
THOMPSON DAVIS & CO., INC.
13F
Company
0.04%
51,770
$37,000 30 Jun 2016
13F
STATE STREET CORP
13F
Company
0.04%
45,300
$33,000 30 Jun 2016
13F
AGRAN LIBBIE
13F
Company
0.04%
44,000
$31,000 30 Jun 2016
13F
Squarepoint Ops LLC
13F
Company
0.03%
41,400
$29,000 30 Jun 2016
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.03%
41,332
$29,000 30 Jun 2016
13F
D. E. Shaw & Co., Inc.
13F
Company
0.03%
33,094
$23,000 30 Jun 2016
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
25,643
$18,000 30 Jun 2016
13F
Commonwealth Equity Services, Inc
13F
Company
0.02%
25,500
$18,000 30 Jun 2016
13F
ALBION FINANCIAL GROUP /UT
13F
Company
0.02%
24,800
$18,000 30 Jun 2016
13F
GUGGENHEIM CAPITAL LLC
13F
Company
0.02%
21,595
$15,000 30 Jun 2016
13F
HBK Sorce Advisory LLC
13F
Company
0.02%
21,109
$15,000 30 Jun 2016
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.02%
20,600
$15,000 30 Jun 2016
13F
ProVise Management Group, LLC
13F
Company
0.02%
19,000
$13,000 30 Jun 2016
13F
WEDBUSH SECURITIES INC
13F
Company
0.01%
17,000
$12,000 30 Jun 2016
13F
New England Private Wealth Advisors LLC
13F
Company
0.01%
15,554
$11,000 30 Jun 2016
13F
Raymond James Financial Services Advisors, Inc.
13F
Company
0.01%
15,500
$11,000 30 Jun 2016
13F
Creative Planning
13F
Company
0.01%
14,781
$10,000 30 Jun 2016
13F
Virtu KCG Holdings LLC
13F
Company
0.01%
12,865
$9,000 30 Jun 2016
13F
BlackRock Fund Advisors
13F
Company
0.01%
12,184
$9,000 30 Jun 2016
13F
CITIGROUP INC
13F
Company
0.01%
11,438
$8,000 30 Jun 2016
13F
COMPTON CAPITAL MANAGEMENT INC /RI
13F
Company
0.01%
10,000
$7,000 30 Jun 2016
13F

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q3 2016

As of 30 Sep 2016, CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by 46 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,293,467 shares. The largest 10 holders included Broadfin Capital, LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Point72 Asset Management, L.P., GSA CAPITAL PARTNERS LLP, TANAKA CAPITAL MANAGEMENT INC, MILLENNIUM MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., GEODE CAPITAL MANAGEMENT, LLC, and KENNEDY CAPITAL MANAGEMENT, INC.. This page lists 46 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2016 vs Q2 2016 Across Filers

Q2 2016 holders
57
Q3 2016 holders
46
Holder diff
-11
Investor Q2 2016 Shares Q3 2016 Shares Share Diff Share Chg % Q2 2016 Value $ Q3 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.